{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:35:23Z","timestamp":1764995723530},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,11,14]],"date-time":"2007-11-14T00:00:00Z","timestamp":1194998400000},"content-version":"vor","delay-in-days":3757,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapeutic Apheresis"],"published-print":{"date-parts":[[1997,8]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Apheresis therapy such as plasma exchange and plasma adsorption has become therapeutic tools in critical care. The indications for apheresis therapy in ICU patients include fulminant hepatic failure, thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS), autoimmune disease, and sepsis. During the past 11 years, 150 patients with various kinds of critical illnesses were treated with apheresis therapy in our ICU, and the overall survival rate was 50%. Apheresis therapy is especially useful in the treatment of a patient with fulminant hepatic failure because liver transplantation is seldom performed in Japan; therefore, the patient should be treated with artificial liver support. When plasma exchange is performed on the critically ill, continuous hemodiafiltration should be performed simultaneously to overcome the adverse effects of plasma exchange such as hypernatremia. metabolic alkalosis. and abrupt changes in colloid osmotic pressure and to enhance the removal rate of the causative middle molecular weight substances of hepatic failure or hepatic coma.<\/jats:p>","DOI":"10.1111\/j.1744-9987.1997.tb00143.x","type":"journal-article","created":{"date-parts":[[2007,11,14]],"date-time":"2007-11-14T19:40:31Z","timestamp":1195069231000},"page":"228-232","source":"Crossref","is-referenced-by-count":19,"title":["Efficacy and Limitation of Apheresis Therapy in Critical Care"],"prefix":"10.1111","volume":"1","author":[{"given":"Hiroyuki","family":"Hirasawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Sugai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohito","family":"Sadahiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,11,14]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000170118"},{"key":"e_1_2_1_3_2","first-page":"38","article-title":"Indication and efficacy of blood purification in the treatment of multiple organ failure","volume":"14","author":"Kitamura N.","year":"1995","journal-title":"Jpn J Apheresis"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002689900076"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01706318"},{"key":"e_1_2_1_6_2","first-page":"21","article-title":"Plasmapheresis in intensive care. Part 1 of 2: History, techniques and complications","volume":"7","author":"Hart GK.","year":"1990","journal-title":"Intensive Cure World"},{"key":"e_1_2_1_7_2","first-page":"80","article-title":"Plasmapheresis in intensive care. Part 2 of 2: Indications for plasmapheresis and plasma exchange in the intensive care unit","volume":"7","author":"Hart GK.","year":"1990","journal-title":"Intensive Care World"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/088506669601100302","article-title":"Clinical applications of therapeutic hemapheresis","volume":"11","author":"Rososhansky S.","year":"1996","journal-title":"Intensive Cure Med"},{"key":"e_1_2_1_9_2","first-page":"83","article-title":"Efficacy of continuous blood purifications for fulminant hepatitis","volume":"14","author":"Ohtake Y.","year":"1995","journal-title":"Jpn J Apheresis"},{"key":"e_1_2_1_10_2","first-page":"30","article-title":"The efficacy of plasma exchange and sequential continuous hemodiafiltration for hepatic failure","volume":"15","author":"Ohtake Y.","year":"1996","journal-title":"Jpn J Apheresis"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050289"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199205213262101"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199205213262102"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204233261705"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02575302"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840200704"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199405000-00012"},{"key":"e_1_2_1_18_2","first-page":"1411","volume":"340","author":"Matsunami H.","year":"1992","journal-title":"Living-related liver transplantation in fulminant hepatic failure. Lancet"},{"key":"e_1_2_1_19_2","first-page":"3634","article-title":"Combination of plasma exchange and continuous hemofiltration as temporary metabolic support for patients with acute liver failure","volume":"18","author":"Matsubara S.","year":"1994","journal-title":"Arfif Organs"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1996.tb00657.x"},{"key":"e_1_2_1_21_2","first-page":"651","volume-title":"Anesthesia, pain, intensive cure and emergency","author":"Hirasawa H.","year":"1993"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1989.tb01556.x"}],"container-title":["Therapeutic Apheresis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1744-9987.1997.tb00143.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1744-9987.1997.tb00143.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T12:50:52Z","timestamp":1698411052000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1744-9987.1997.tb00143.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["10.1111\/j.1744-9987.1997.tb00143.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1744-9987.1997.tb00143.x","archive":["Portico"],"relation":{},"ISSN":["1091-6660","1526-0968"],"issn-type":[{"value":"1091-6660","type":"print"},{"value":"1526-0968","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8]]}}}